期刊文献+

EB病毒BNLF-1基因在淋巴瘤和急性白血病的表达及临床意义 被引量:4

Expression of EBV-BNLF-1 Gene in Lymphoma and Acute Leukemia and its Clinical Significance
下载PDF
导出
摘要 目的 研究 EB病毒 BNL F- 1基因在淋巴瘤和急性白血病的表达及含量 ,探讨该基因表达与淋巴瘤、急性白血病的发病机制与预后的关系。 方法 采用 Amplisensor荧光定量 PCR技术 ,检测淋巴瘤和急性白血病患者血液或骨髓 EB病毒 BNL F- 1基因片段 ,同时测定血清中 EB病毒 VCA- Ig A抗体滴度。 结果  (1)淋巴瘤BNL F- 1基因表达高于急性淋巴细胞白血病 (急淋 )、急性非淋巴细胞白血病 (急非淋 )和对照组 ;急淋高于急非淋和对照组 ;淋巴瘤 VCA- Ig A阳性率高于急非淋和对照组 ;急淋高于对照组 ;急非淋与对照组无显著差异。 (2 )淋巴瘤BNL F- 1基因含量高于急淋、急非淋 ;急淋高于急非淋。(3) T、B细胞淋巴瘤 BNL F- 1基因表达无显著差异。(4)淋巴瘤 BNL F- 1基因含量越高 ,生存期越短。 结论  BNL F- 1基因可能是 EBV的致癌基因之一 ;其阳性率及含量的高低可作为淋巴瘤及急淋和急非淋的鉴别诊断依据之一 ;BNL F- Objective\ To study the expression and quantity of Epstein\|Barr virus(EBV) BamHI\|N leftward reading fragment(BNLF\|1) gene fragment and its clinical significance in lymphoma, acute lymphocytic leukemia(ALL), and acute non\|lymphocytic leukemia(ANLL).\ Methods\ The BNLF\|1 gene fragment was amplified and quantified by using quantitative polymerase chain reaction(PCR), and VCA\|IgA was detected by enzyme immunoassay.\ Results\ (1)The positive expressive rate of BNLF\|1 was higher in lymphoma than that in ALL, ANLL, and the control.\ It was higher in ALL than that in ANLL and in the control.\ The positive rate of VCA\|IgA was higher in lymphoma than that in ALL and the control.\ It was higher in ALL than that in the control.\ There were no significantly difference between \{ANLL\} and the control.\ (2)The quantity of BNLF\|1 was higher in lymphoma than that in ALL and \{ANLL\}.\ It was higher in ALL than that in ANLL.\ (3)There were no significantly difference of expressive rate and quantity of BNLF\|1 gene between T cell and B cell lymphoma.\ (4)It showed negative correlation between the quantity of BNLF\|1 gene and life span in lymphoma.\ Conclusion\ BNLF\|1 may be one of carcinogens of lymphoma and acute lymphocytic leukemia.\ BNLF\|1 may serve as one of the criteria for differential diagnosis of lymphoma, ALL, and ANLL.\ The higher quantity of BNLF\|1 gene, the shorter life span is.
出处 《福建医科大学学报》 2001年第4期328-331,共4页 Journal of Fujian Medical University
基金 福建省卫生厅科研基金资助项目 (960 98)
关键词 淋巴瘤 白血病 BNLF-1基因 聚合酶链反应 疱疹病毒 急性白血病 lymphoma leukemia BamHI\|N leftward reading fragment polymerase chain reaction herpesvirus type 4,human
  • 相关文献

参考文献6

  • 1Kirstsian S,Suat -Cheng P,Brake SA,et al.Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus ( EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas[].Blood.1994
  • 2Ohshima-K,Kikuchi M Shibata T,et al.Clonal analysis of Hodgkins disease shows absence of TCR Ig gene rearrangement compared with T cell -rich B-cell lymphoma and incipient adult T-cell leukemia lymphoma[].Leukemia and Lymphoma.1994
  • 3Baichwal VR,Hammerschmidt W,Sugden B.Characterization of the BNLF-1 oncogene of Epstein-Barr virus[].Current Topics in Microbiology and Immunology.1989
  • 4Hammerschmidt W,Sugden B,Baichwal VR.The transforming domain alone of the latent membrane protein of EpsteinBarr virus is toxic to cells when expressed at high levels[].Journal of Virology.1989
  • 5David J,Alice E,Edith B,et al.Epstein-Barr virus burden in Hodgkins disease is related to latent membrane protein gene expression but not to active virus replication[].Blood.1992
  • 6Hammarskjold M L,Simurdra M C.Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NFkappa B activity[].Journal of Virology.1992

同被引文献38

  • 1OHSHIMA K, SUZUMIYA J, KANDA M, et al. Genotypie and phenotypic alterations in Epstein - Barr virus - associated lymphoma[J]. Histopathology, 1999, 35(6) : 539 -550.
  • 2TOSATO G, TATA K, ANGIOLILLO A L, et al. Epstein - Barr virus asan agent of hemato logical disease [ J ]. Balliere' s Clin Hematol, 1995, 8 (1): 165-199.
  • 3GAN R, YIN Z, LIU T, et al. Cyclosporine A effectively inhibits graft - versus - host disease during development of Epstein - Barr virus - infected human B cell lymphoma in SCID mouse [ J ]. Cancer Sci, 2003, 94(9): 796- 801.
  • 4ZETTERBERG H, BORESTROM C, NILSSON T, et al. Multiple EBNA1 -binding sites within oriPI are required for EBNAI -dependent transactivation of the Epstein - Barf virus C promoter[ J ]. Int J Oncol, 2004, 25 (3) : 693 - 696.
  • 5GULLEY M L, GLASER S L, CRAIG F E, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein - Barr virus in Hodgkin lymphoma[J]. Am J Clin Pathol, 2002, 117(2) : 259 -267.
  • 6NOORALI S, NASIR M I, PERVEZ S. Characterization of angio- immunoblastic T- cell lymphomas (AILT) and its association with Epstein - Barrvirus ( EBV ) in Pakistanipatients [ J ]. Coll Physicians Surg Pak, 2005, 15(7) : 404 -408.
  • 7BOLLARD C M, COOPER L J, HESLOP H E. Immunotherapy targeting EBV - expressing lymphoproliferative diseases [ J ]. Best Pract Res Clin Haematol, 2008, 21 (3) : 405 -420.
  • 8Bouman SJ Honmtological manifeation of rheumatoid arthritis scand[J].J Rheumatol 2002,31:251-259.
  • 9Van de kolk 2 E,Grillo-lope2AJ-Baars J W et al.Treameat of relapsed B-cell non-Hodgkin's lymphoma uith a Combination ofchimere ant-CD20 monoclonal antibodies and:G-csf:final report on-safety and efficaey[J].Lewkemia,2003,17(8):1658-1664.
  • 10Sugimachi k lefrere F,Hermine o Betal,Fludarrabine:an effective treatment in palients splentic lymphoma with villous lymphoayles[J].lerkenia.2002,14:573-575.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部